SAN DIEGO (AP) _ Kura Oncology Inc. (KURA) on Monday reported a loss of $15 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 40 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.
Kura Oncology shares have declined 26 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $11.37, a drop of 24 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KURA at https://www.zacks.com/ap/KURA